Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

Jan B. Vermorken(Antwerp University Hospital), A.M.E. Claessen(University of Amsterdam), Harm van Tinteren(Netherlands Comprehensive Cancer Organisation), Helen Gall(University of Amsterdam), Renate Ezinga(Netherlands Comprehensive Cancer Organisation), Sybren L. Meijer(University of Amsterdam), Rik J. Scheper(University of Amsterdam), Chris J.L.M. Meijer(University of Amsterdam), Elisabeth Bloemena(University of Amsterdam), Janet H. Ransom(International Research Associates (United States)), Michael G. Hanna(International Research Associates (United States)), Herbert M. Pinedo(University of Amsterdam)
The Lancet
January 1, 1999
10.1016/s0140-6736(98)07186-4
Cited by 503Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis